The impact of COVID-19 on breast cancer screening: a peek behind the lecture with Dr Katherine Crew

Please introduce yourself, your research background and current research interests. My name is Katherine Crew and I’m a breast medical oncologist at Columbia University Irving Medical Center in New York City (NY, USA). I also direct the Clinical Breast Cancer Prevention Program at the Herbert Irving Comprehensive Cancer Center. My research focuses on implementing breast cancer risk assessment into clinical practice and adopting risk-stratified approaches to breast cancer screening and prevention. How has the COVID-19 pandemic impacted breast cancer screening? Early during the COVID-19 pandemic in March 2020, there was a dramatic decrease in cancer screening, particularly mammography screening, by...